Skip to main content
. 2023 Sep 29;32:66–97. doi: 10.1016/j.bioactmat.2023.09.015

Fig. 25.

Fig. 25

PDT-mediated ferroptosis cancer nanomedicine with MRI/FI guidance. (a) Preparation and characterization of Fe3O4@PGL NPs. (b) Real-time FI using Fe3O4@PGL NPs and their biodistribution. (c) MR contrast enhancing property of Fe3O4@PGL NPs. (d) In vivo PDT of Fe3O4@PGL NPs. Reproduced with permission [127]. Copyright 2021, American Chemical Society.